A small-molecular-weight drug originally developed to treat cancer produces sustained reduction in body weight in obese mice by a novel hypothalamic mechanism. The findings suggest new targets for the development of anti-obesity drugs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Loftus, T.M. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379–2381 (2000).
Kumar, M.V., Shimokawa, T., Nagy, T.R. & Lane, M.D. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice. Proc. Natl. Acad. Sci. USA 99, 1921–1925 (2002).
Halaas, J.L. et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543–546 (1995).
Makimura, H. et al. Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting. Diabetes 50, 733–739 (2001).
Moule, S.K. et al. Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells. Biochem. J. 311, 595–601 (1995).
Niswender, K.D. et al. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413, 794–795 (2001).
Shepherd, P.R., Withers, D.J. & Siddle, K. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling. Biochem. J. 333, 471–490 (1998).
Yang, X.J., Kow, L.M., Funabashi, T. & Mobbs, C.V. Hypothalamic glucose sensor: Similarities to and differences from pancreatic β-cell mechanisms. Diabetes 48, 1763–1672 (1999).
Obici, S. et al. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271–275 (2002).
Shimokawa, T., Kumar, M.V. & Lane, M.D. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proc. Natl. Acad. Sci. USA 99, 66–71 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mobbs, C., Makimura, H. Block the FAS, lose the fat. Nat Med 8, 335–336 (2002). https://doi.org/10.1038/nm0402-335
Issue Date:
DOI: https://doi.org/10.1038/nm0402-335
This article is cited by
-
Light-emitting diode (LED) photobiomodulation regulates thermogenesis and lipogenesis markers in adipose tissue and improves anthropometric and metabolic parameters in obese mice
Lasers in Medical Science (2023)
-
Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice
Diabetologia (2017)
-
Expression Profile in Omental and Subcutaneous Adipose Tissue from Lean and Obese Subjects. Repression of Lipolytic and Lipogenic Genes
Obesity Surgery (2011)
-
Effect of Genetic Variation in the Human Fatty Acid Synthase Gene (FASN) on Obesity and Fat Depot‐Specific mRNA Expression
Obesity (2010)
-
The Gene Expression of the Main Lipogenic Enzymes is Downregulated in Visceral Adipose Tissue of Obese Subjects
Obesity (2010)